Goldman Sachs
SGRY icon

Goldman Sachs’s Surgery Partners SGRY Stock Holding History

Goldman Sachs’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Sell
1,280,552
-679,134
-35% -$9.75M ﹤0.01% 2707
2025
Q4 		$30.3M Buy
1,959,686
+1,647,714
+528% +$30.3M ﹤0.01% 1966
2025
Q3 		$6.75M Sell
311,972
-240,296
-44% -$5.36M ﹤0.01% 3362
2025
Q2 		$12.3M Sell
552,268
-147,912
-21% -$3.29M ﹤0.01% 2576
2025
Q1 		$16.6M Sell
700,180
-569,216
-45% -$13.5M ﹤0.01% 2200
2024
Q4 		$26.9M Buy
1,269,396
+192,832
+18% +$5.06M ﹤0.01% 1829
2024
Q3 		$34.7M Sell
1,076,564
-402,620
-27% -$11.9M 0.01% 1557
2024
Q2 		$35.2M Buy
1,479,184
+698,295
+89% +$17.9M 0.01% 1420
2024
Q1 		$23.3M Sell
780,889
-231,885
-23% -$7.25M ﹤0.01% 1710
2023
Q4 		$32.4M Sell
1,012,774
-231,971
-19% -$6.73M 0.01% 1498
2023
Q3 		$36.4M Buy
1,244,745
+288,949
+30% +$10.4M 0.01% 1330
2023
Q2 		$43M Buy
955,796
+629,925
+193% +$24M 0.01% 1212
2023
Q1 		$11.2M Sell
325,871
-386,771
-54% -$12.6M ﹤0.01% 2313
2022
Q4 		$19.9M Buy
712,642
+492,645
+224% +$13M ﹤0.01% 1971
2022
Q3 		$5.15M Buy
219,997
+145,096
+194% +$4.63M ﹤0.01% 3108
2022
Q2 		$2.17M Buy
74,901
+8,942
+14% +$391K ﹤0.01% 3977
2022
Q1 		$3.63M Sell
65,959
-80,529
-55% -$3.98M ﹤0.01% 3644
2021
Q4 		$7.82M Sell
146,488
-8,347
-5% -$387K ﹤0.01% 2988
2021
Q3 		$6.56M Buy
154,835
+100,726
+186% +$5.14M ﹤0.01% 3122
2021
Q2 		$3.6M Sell
54,109
-104,439
-66% -$5.67M ﹤0.01% 3651
2021
Q1 		$7.02M Buy
158,548
+131,830
+493% +$4.89M ﹤0.01% 2852
2020
Q4 		$775K Sell
26,718
-105,787
-80% -$2.63M ﹤0.01% 4355
2020
Q3 		$2.9M Buy
132,505
+18,381
+16% +$327K ﹤0.01% 3306
2020
Q2 		$1.32M Sell
114,124
-420,959
-79% -$4.61M ﹤0.01% 3769
2020
Q1 		$3.49M Sell
535,083
-195,090
-27% -$2.78M ﹤0.01% 2918
2019
Q4 		$11.4M Sell
730,173
-840,938
-54% -$9.54M ﹤0.01% 2332
2019
Q3 		$11.6M Buy
1,571,111
+431,633
+38% +$3.09M ﹤0.01% 2205
2019
Q2 		$9.28M Buy
1,139,478
+1,071,843
+1,585% +$10.7M ﹤0.01% 2410
2019
Q1 		$763K Buy
67,635
+9,135
+16% +$115K ﹤0.01% 4204
2018
Q4 		$572K Buy
58,500
+45,599
+353% +$612K ﹤0.01% 4285
2018
Q3 		$213K Buy
+12,901
New +$206K ﹤0.01% 4891
2018
Q2 		– Sell
-458,907
Closed -$7.87M – 5980
2018
Q1 		$7.87M Sell
458,907
-153,117
-25% -$2.39M ﹤0.01% 2538
2017
Q4 		$7.41M Buy
+612,024
New +$5.85M ﹤0.01% 2679
2017
Q1 		– Sell
-12,504
Closed -$198K – 6983
2016
Q4 		$198K Buy
12,504
+2,410
+24% +$40.1K ﹤0.01% 5777
2016
Q3 		$204K Sell
10,094
-13,645
-57% -$251K ﹤0.01% 5826
2016
Q2 		$425K Buy
+23,739
New +$353K ﹤0.01% 5004
2016
Q1 		– Sell
-28,379
Closed -$581K – 7300
2015
Q4 		$581K Buy
+28,379
New +$542K ﹤0.01% 4790

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs's SGRY Position: Q1 2026 in Review

Goldman Sachs reduced its Surgery Partners (SGRY) stake by 35% in Q1 2026, selling an estimated $9.75M and leaving 1,280,552 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Goldman Sachs first reported a position in SGRY in Q4 2015 and has held it in 37 quarters since. The position peaked at $43M in Q2 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Goldman Sachs held 1,280,552 shares of Surgery Partners worth $15.3M as of Q1 2026.
  • Goldman Sachs sold 679,134 Surgery Partners shares in Q1 2026, an estimated $9.75M.
  • Surgery Partners made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2707 holding.
  • Goldman Sachs first reported a position in Surgery Partners in Q4 2015 and has held it in 37 quarters since.
  • Goldman Sachs's Surgery Partners position peaked at $43M in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.